{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "13013 Children with Henoch Schonlein Purpura 3.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MANAGEMENT AND FOLLOW UP OF CHILDREN WITH IMMUNOGLOBULIN A VASCULITIS (HENOCH SCHONLEIN PURPURA )"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "13013"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Nurses, Junior Doctors, Paediatricians, Community Paediatric Specialist Nurses"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "nd2 September 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "1st September 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Update and improve practice NICE guidance 47"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's & Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Dr Job Cyriac, Consultant Paediatrician"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Datta, Clinical Lead Paediatrics"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "23rd July 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "25th July 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: September 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "13013 Children with Henoch Schonlein Purpura 3.0.003.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 21,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Melanie Chambers"
                    },
                    {
                        "text": "Lead Nurse Children and young people"
                    },
                    {
                        "text": "23rd July 2019"
                    },
                    {
                        "text": "Mary Stebbens"
                    },
                    {
                        "text": "Clinical Facilitator Children and Young People"
                    },
                    {
                        "text": "Mel Hodge"
                    },
                    {
                        "text": "Ward Sister"
                    },
                    {
                        "text": "Dr A Rao/ A. Cuthbertson"
                    },
                    {
                        "text": "Clinical Director"
                    },
                    {
                        "text": "Dr Datta"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Joseph"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Cyriac"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Agrawal"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Hassan"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Huxstep"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Cahavakula"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Pradeep"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Das"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Annam"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Lim"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Nambiar"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Ottayil"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Muthumeenal"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Dr Lethaby"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "Ruth Byford"
                    },
                    {
                        "text": "Warner Library"
                    },
                    {
                        "text": "26th July 2019"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Paediatric Assessment Unit Operational Policy 04064 Safeguarding children and Young People policy 0-18 years 09026 Discharge policy for children and young people 0-16 05118 Chaperone policy 04071 Policy for Standard infection prevention precautions 04072 Hand Hygiene policy 09127A Interpreting and translation policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Dr Dean Lethaby and Dr J Cyriac"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "28th May 2013"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Dr Dean Lethaby and Dr J Cyriac"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "10th June 2016"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Dr J Cyriac and Dr Pushpa Ghavalkar"
                    },
                    {
                        "text": "Full review"
                    },
                    {
                        "text": "2nd September 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Index   Purpose   Equality Impact Assessment   Background   Symptoms and Signs   Physical examination   Causes   Differential diagnosis   Complications in children with HSP 9.0  Investigations and Management at Presentation 10.0  Management to monitor for renal involvement 11.0  Discharge and follow-up 12.0  Staff Training   Infection Prevention   Audit and Monitoring   Communication   References   Appendices"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "A Differential Diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "B Purpura pathway"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "C Blood pressure \u2013 Boys"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "text": "D Blood pressure - Girls"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "text": "E GP letter"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "text": "F Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This guideline is to direct the initial management, follow up and, where appropriate, onward referral to tertiary care of children and young people with IgA Vasculitis (Henoch Schonlein purpura)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individual. (Refer to Appendix F)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 3.1,
                "text": "Immunoglobulin A vasculitis (IgA vasculitis) [IgAV]; formerly called Henoch- Schonlien Purpura (HSP) is the most common form of systemic vasculitis in children. Ninety percent of cases occur in the paediatric age group. In contrast to many other forms of systemic vasculitis, IgAV (HSP) is self-limited in the great majority of cases."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "It is most common in children under 5 years but can affect any age and the prognosis is generally good. The principal aim of management and follow up is to control symptoms and monitor and treat renal involvement which can otherwise lead to renal damage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The majority of children with IgAV (HSP) have no long-term effects and require only supportive care but for those with renal involvement the management is different and so they must be identified as early as possible to prevent progression of renal damage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "Recurrence of HSP is reported in about one-third of affected children and generally occurs within four months of the initial episode. Recurrences tend to be milder and briefer than the initial episode, and they occur more commonly in patients with nephritis, in those with evidence of acute inflammation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 3.5,
                "text": "This guideline provides a generic pathway for follow up which includes triggers for referral to tertiary nephrology services where appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Symptoms and Signs"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Purpura and similar skin lesions in the presence of one or more of the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "text": "Diffuse abdominal pain (affecting up to 30% of patients);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 1,
                "text": "Arthritis or arthralgia (affecting up to 75% of patients);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "text": "Renal involvement (affecting up to 50% of patients)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The rash often begins with erythematous, macular, or urticarial wheals. The wheals then coalesce and evolve into the typical ecchymoses, petechiae, and palpable purpura."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "It typically appears in gravity/pressure-dependent areas such as the lower extremities, the buttocks are often involved in toddlers, and the face, trunk, and upper extremities in non-ambulatory children. The classic rash of HSP is not the initial presenting sign in about one-quarter of affected children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The arthritis/arthralgia is usually transient or migratory, typically oligoarticular (one to four joints), and non-deforming. It usually affects the lower extremity large joints (hips, knees, and ankles), or less commonly the upper extremities (elbows, wrists, and hands)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "Gastrointestinal symptoms range from mild (nausea, vomiting, abdominal pain, and transient paralytic ileus) to more significant findings (gastrointestinal haemorrhage, bowel ischemia and necrosis, intussusception, and bowel perforation). Gastrointestinal pain associated with HSP is caused by submucosal haemorrhage and oedema."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "Renal involvement most commonly presents with haematuria with or without red cell casts and +/- proteinuria. Nephrotic range proteinuria, an elevated serum creatinine, and/or hypertension, which are present in a minority of patients, are associated with an increased risk of progressive disease. Scrotal involvement in boys may be the presenting symptom; clinical findings include pain, tenderness, and swelling of the involved testicle and/or scrotum."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Criteria for Diagnosis (European League Against Rheumatism (EULAR) criteria (Ozen, 2010):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "Diagnosis is primarily clinical"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "Palpable purpura, not thrombocytopenic/petechiae (mandatory)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "text": "And \u22651 of the following"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Indicators for renal involvement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 1,
                "text": "Haematuria/ Red blood cell casts;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": ">5 red cells per high power field;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "text": "OR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "\u22651+ on dipstick;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 1,
                "text": "OR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "Red blood cell casts in urinary sediment;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 1,
                "text": "Proteinuria;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "0.3g/24hrs or >30mmol/ mg of urine albumin to creatinine ratio on an early morning sample of urine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 1,
                "text": "4.8.1  Indicators for renal involvement: Macro or microscopic haematuria confirms the renal involvement of IgAV. Level of proteinuria along with haematuria indicates the severity of the renal involvement. Proteinuria on its own is not generally a feature of IgAV renal disease; however with history of IgAV shouldn't be ignored. If the proteinuria is fixed needs further evaluation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Physical Examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Verbal consent should be gained from child/parent and age appropriate explanation should be given. Confirm with the child/young person that they are happy for the accompanying parent/guardian to be present during examination."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Consider safeguarding children issues (04064)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Follow the Chaperone Policy (05118) if patient is not accompanied by parent/guardian when a physical examination takes place."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Undertake a full systemic examination, including weight, height, blood pressure and other vital signs particularly focussing on the joints, abdomen and skin. In addition a urine dipstick also is a must."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Causes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The pathogenetic mechanisms underlying HSP are poorly understood. Widespread abnormalities in Immunoglobulin A have been described. Complement abnormalities have also been described in association with HSP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Differential Diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix A)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Complications in Children with HSP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Orchitis and scrotal swelling may occur in boys with Henoch-Sch\u00f6nlein purpura. Severe scrotal oedema may cause testicular torsion, which requires emergency surgical evaluation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Severe bleeding per rectum causing haemodynamic collapse and acute surgical emergencies including intussusception and appendicitis are also associated with HSP and should be considered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Investigations and Management at Presentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "FBC, blood film, U+E's, LFT's, Coagulation screen, urine dipstick, blood pressure and any other clinically relevant tests according to the presentation:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "No specific laboratory tests for diagnosis, but these investigations are aimed at excluding other diagnosis & assessing the extent of organ involvement;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 1,
                "text": "All patients need weight, height, BP and urine dipstick"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "text": "Initial investigations include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "FBC, (PLT \u2013 normal);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "Coagulation;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "Urea and electrolytes;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "Urine dipstix analysis;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "If proteinuria more than 0.3 gm/L (1 + or more on Siemens Multistix  SG) then early morning urine protein: creatinine ratio."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 1,
                "prefix": 9.2,
                "text": "Criteria for admission"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "These children generally do not need admission. Most symptoms can be treated conservatively. Only children with red flag symptoms indicating complications such as haematemesis, bleeding per rectum, intussusception etc. will need admission."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 1,
                "text": "9.2.1 Hospitalization is warranted for the following indications:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Inability to maintain adequate hydration with oral intake"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Severe abdominal pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Significant gastrointestinal bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Changes in mental status"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Severe joint involvement limiting ambulation and/or self-care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "Macroscopic haematuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Renal insufficiency (elevated creatinine), hypertension, and nephritis /or nephrotic syndrome"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 9.3,
                "text": "Management:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "9.3.1 Symptom control should be undertaken and acute signs (although rare) should be managed appropriately with consideration of surgical and orthopaedic input for abdominal and joint problems respectively. Paediatric Consultant Management of IgAV (HSP) includes supportive care, symptomatic therapy and targeted treatment to decrease the risk of complications:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "Majority of patients with IgAV (HSP) recover spontaneously, and most patients may be cared for in the ambulatory setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "Therapy is primarily supportive and includes adequate hydration, rest, and symptomatic relief of pain."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Oedema of the lower extremities, buttocks, and genital area is improved with bed rest and/or elevating the affected area."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 1,
                "text": "9.3.2 Pain Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "Paracetamol can be used as a first line for pain control;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 1,
                "text": "As a second line Codeine can also be considered in older children. They should therefore be considered with caution on a case by case basis and only if the use of alternative analgesia (i.e. Paracetamol and Codeine) is unsuccessful. NSAIDs generally should not be given to children with gastrointestinal involvement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "text": "Severe pain:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Clinical experience and observational data suggest that the anti- inflammatory effects of glucocorticoids can relieve many of the manifestations of IgAV (HSP), including rash, arthritis/arthralgias, scrotal pain/orchitis, and gastrointestinal pain;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "However, glucocorticoids are not usually indicated for these manifestations, unless symptoms are severe, given the limited data and the potential side effects of the therapy;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Patients with IgAV (HSP) who have gastrointestinal involvement, including bowel wall oedema, may have disrupted absorption of enteral"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "medications."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 1,
                "prefix": 9.4,
                "text": "Indications of glucocorticoids:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "Prednisolone 1 to 2 mg/kg per day, maximum dose of 60 to 80 mg per day) only in patients with:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Intractable abdominal pain significant enough to substantially limit their oral intake;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "Intravenous methylprednisolone may be more beneficial early in the disease course, when patients have active gastrointestinal disease, due to submucosal oedema and haemorrhage altering absorption of oral medications;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "When glucocorticoids are used for treating IgAV (HSP), it is important to remember that, although the inflammation may be ameliorated, the pathophysiology of the disease does not appear to be altered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 1,
                "text": "In addition, patients who are treated with glucocorticoids for severe abdominal pain require particular vigilance since these medications can obscure the signs and symptoms of abdominal catastrophes associated with IgAV (HSP)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Management to Monitor for Renal Involvement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "With any renal involvement of HSP there is usually microscopic haematuria \u22651+ which can persist for a number of months. It is the proteinuria which suggests the severity of the renal involvement and this should be carefully monitored."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "In order to plan appropriate follow up, children diagnosed with HSP should have a urine dipstick at the time of initial presentation and be stratified into either the Standard pathway (Protein negative on dipstick with or without microscopic haematuria) or the Proteinuria pathway (Protein \u22651+ with coexisting haematuria \u22651+) in order to plan follow up."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix B)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Any patient found to be positive for protein and blood (Protein \u22651+ and haematuria \u22651+) on dipstick should have primary investigations at the initial presentation and at any subsequent review if the Proteinuria and haematuria is found to persist or arise. To avoid confusion with orthostatic proteinuria, only early morning urine should be analysed for proteinuria at follow up visits."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Primary investigations:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "Urea + electrolytes + Creatinine;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Serum Albumin;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "Urine Albumin: creatinine ratio;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Urine Microscopy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "A blood pressure should be recorded at the initial presentation and every subsequent review and stratified on the centile charts attached. (Refer to Appendix C and D)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "prefix": 10.6,
                "text": "Any child meeting the referral criteria at any review should exit the pathway, have Paediatric Consultant input within 24hrs, consideration of secondary investigations and a discussion with tertiary nephrology colleagues if the Consultant involved believes it to be necessary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 10.7,
                "text": "Secondary investigations to be considered for patients meeting the referral/exit criteria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "text": "Antinuclear antibody (ANA);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "Antistreptococcal titre (ASOT);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "text": "Double stranded DNA (dsDNA);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "Anti-neutrophil cytoplasmic antibody (ANCA);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "Complement profile \u2013 C3, C4;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "Immunoglobulin profile;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Renal Ultrasound."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 10.8,
                "text": "Any child on the standard pathway should transfer to the Proteinuria pathway if they become Protein \u22651+ and Haematuria \u22651+ at any point."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Discharge and Follow-up"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "On discharge from the initial presentation children on the standard pathway should have a GP discharge summary containing guidance re follow-up as per template."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix E)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "For children on the Proteinuria pathway all relevant appointments should be organised at time of discharge. A referral to children's community nurses Team at Provide will need to be completed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "If a child moves from the Standard to the Proteinuria pathway at subsequent review by GP all further relevant appointments should be organised at this point."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "If the child has persisting Haematuria \u22651+ at 6 months review on either pathway they should be referred back to a Paediatric Consultant clinic to have a longer and less frequent follow up of the urine and blood pressure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "prefix": 11.5,
                "text": "Indications for referral to Paediatric Nephrologist:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "Nephritic syndrome (haematuria, hypertension, oliguria, abnormal GFR);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Nephrotic syndrome (proteinuria >200 mg/ mmol creatinine,hypoalbuminaemia <25 g/Oedema);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Isolated Hypertension, low grade proteinuria;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Abnormal GFR."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "prefix": 11.6,
                "text": "The aim is to detect early renal involvement and to initiatimmunosuppressive treatment, so as to avoid renal damage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Staff Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "All medical and nursing staff are to ensure that their knowledge, competencies and skills are up-to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "During induction process junior medical staff will receive instruction on current policies and guidelines."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "At case presentation and junior doctor teaching will discuss serious cases relating to HSP, and learn from the outcomes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "Where a patient's notes have demonstrated that the appropriate action has not been taken a \u2018risk event form' is to be completed. This will address any further training needs for staff that require updating."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "All staff should follow Trust guidelines on infection prevention ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention using Aseptic Non-Touch Technique (ANTT) when carrying out procedures."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Where a child's notes have demonstrated that the appropriate action has not been taken a \u2018risk event form' is to be completed. This will address any further training needs for staff that require updating."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Laboratories should monitor resistance patterns of urinary pathogens and make this information routinely available to prescribers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "Annual audit of children admitted with Urinary Tract Infections against this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Communication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Approved guidelines are uploaded to the intranet and website."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Approved guidelines will be disseminated to appropriate staff via email after ratification of guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "Gardner-Medwin, J.M., Dolezalova, P., Cummins, C., Southwood, T.R., 2002. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet, 360(9341), pp1197\u2013 1202."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "Narchi, H., 2005. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Archives of Disease in Childhood, 90(9) pp916\u2013 920."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "Weiss, P.F., Feinstein, J.A., Luan, X., Burnham, J.M., Feudtner, C., 2007. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics, 120(5), pp1079\u20131087."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "Dillon, M.J., Ozen, S., 2006. A new international classification of childhood vasculitis. Pediatric Nephrology, 21(9), pp1219-1222"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "www.uptodate.com. Accessed July 2019"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "Tizard, E.J., 1999. Henoch-Schonlein purpura. Archives of Disease in Childhood, 80(4), pp380-383"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "Kleigman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders; 2007"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Gedalia, A., 2004. Henoch-Sch\u00f6nlein purpura. Current Rheumatology Reports,6(3),pp195-202."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Henoch Schonlein purpura - A five year review and proposed pathway. Watson, L., Richardson, A.R., Holt, R.C., Jones, C.A., Beresford, M.W. 2012. Henoch-Schonlein purpura \u2013 a 5-year review and proposed pathway. PLoS One, 7(1), e29512"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "Supportive Care Protocols. Paediatric Haematology & Oncology. Version 5.0 August 2011"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 1,
                "text": "Appendix A Differential Diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Acute abdomen  Acute or subacute onset of abdominal pain or rigidity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "Acute hemorrhagic  Small vessel leukocytoclastic vasculitis affecting children four to 24 oedema  months of age; rapid onset of purpuric lesions on face, ears, and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "extremities; associated oedema of limbs and face"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "text": "Hypersensitivity  Small-vessel vasculitis associated with abrupt onset of a rash (leukocytoclastic)  (palpable purpura most common); fever, malaise, myalgia, and vasculitis  anorexia after exposure to triggering antigen (e.g., drug, infectious"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "agent)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "Inflammatory bowel  Diarrhoea (bloody or non-bloody), abdominal pain, cramping, fever, disease*  and weight loss"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "Juvenile rheumatoid  Insidious or abrupt onset of morning stiffness or arthralgia that may arthritis  be associated with spiking fevers and an evanescent salmon-pink"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "rash"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "text": "Kawasaki disease  Child with fever for five days or longer; associated with extensive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "text": "polymorphous rash, bilateral conjunctival injection, changes of the lip and oral cavity, unilateral cervical lymphadenopathy, and extremity changes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "text": "Leukaemia  Nonspecific symptoms of fever, easy bleeding, skin findings (e.g.,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "text": "petechiae, purpura), bone pain, fatigue, hepatosplenomegaly, lymphadenopathy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "text": "Meningococcemia  Malaise, fever, rash (e.g., maculopapular rash, petechiae,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "text": "ecchymosis), and hypotension with possible associated symptoms of meningitis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "Polyarteritis nodosa  Multisystem involvement from segmental inflammatory, necrotizing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "text": "vasculitis of the small- and medium-sized muscular arteries leading to general symptoms of fever, weakness, weight loss, malaise, myalgia, rash (e.g., livedo reticularis, purpura), headache, and abdominal pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "Thrombocytopenic  Thrombocytopenia associated with petechia or purpura; bleeding purpura  (e.g., gingival, gastrointestinal, mucocutaneous); symptoms of end-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "organ ischemia (in patients with thrombotic disease)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "Wegener  Granulomatous vasculitis with a characteristic triad of involvement of Granulomatosis  the upper airway (e.g., otitis media, sinusitis, rhinitis), lungs (e.g.,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "text": "pulmonary infiltrates), and kidneys; rash, arthritis/arthralgias, and nervous system (peripheral and central)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 1,
                "text": "Appendix B Purpura Pathway"
            }
        },
        {
            "type": "image",
            "sequence_num": 180,
            "data": {
                "url": "13013 Children with Henoch Schonlein Purpura 3.0.004.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 1,
                "text": "The adapted Alder Hey Henoch Schonlein purpura pathway \u2013 stratifying follow up based on the presence or absence of Proteinuria and Haematuria at presentation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 1,
                "text": "Appendix C"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 1,
                "text": "Blood Pressure - Boys"
            }
        },
        {
            "type": "table",
            "sequence_num": 184,
            "data": {
                "num_rows": 1,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "prefix": 17.0,
                "text": "Blood pressure levels for the 90th and 95th percentiles of blood pressure for boys age 1 to  years by percentiles of height"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 1,
                "text": "Appendix D"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 1,
                "text": "Blood Pressure - Girls"
            }
        },
        {
            "type": "image",
            "sequence_num": 188,
            "data": {
                "url": "13013 Children with Henoch Schonlein Purpura 3.0.006.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "Blood pressure levels for the 90th and 95th percentiles of blood pressure for girls age 1 to 17 years by percentiles of height"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 1,
                "text": "Appendix E GP Letter"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 1,
                "text": "Dear GP,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 0,
                "text": "Please undertake a urine dipstick and blood pressure check at 1 month, 3 months and 6 months from the initial presentation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "If the child meets any of the below criteria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "Protein \u22651+ with co-existing haematuria \u22651+ on early morning urine dipstick"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 1,
                "text": "The BP is above (insert appropriate 95th centile BP here using appendix 1 or 2 as appropriate)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "text": "There is frank (visible) haematuria (not microscopic haematuria)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "Please discuss with the Paediatric Registrar on call who will organise a community nurse next day review or a same day review on the Paediatric assessment unit as appropriate according to the findings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Please note that any child found to have significant Proteinuria alone should be managed accordingly and does not come under the remit of this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "text": "If the child is found to have persistent haematuria \u22651+ at the 6 month review please refer back to a Paediatric Consultant clinic via the standard clinic referral pathway."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "text": "Management and Follow up of Children with Henoch Schonlein Purpura / 13013 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 0,
                "text": "Management and Follow up of Children with Henoch Schonlein Purpura / 13013 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 1,
                "text": "Appendix F:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 1,
                "text": "Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Management and Follow up of Children with Henoch Schonlein Purpura / 13013"
            }
        },
        {
            "type": "table",
            "sequence_num": 206,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 1,
                "text": "Name  Job Cyriac  Job Title  Consultant Paediatrician  Date  June 2019"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "prefix": 17.0,
                "text": ""
            }
        }
    ]
}